Refine
Year of publication
Document Type
- Preprint (682)
- Article (496)
- Conference Proceeding (2)
- Book (1)
- Other (1)
Has Fulltext
- yes (1182)
Keywords
- Heavy Ion Experiments (20)
- Hadron-Hadron Scattering (11)
- Hadron-Hadron scattering (experiments) (11)
- LHC (9)
- Heavy-ion collision (6)
- Mammakarzinom (6)
- breast cancer (6)
- ALICE experiment (4)
- Behandlung (4)
- Collective Flow (4)
- Jets (4)
- Quark-Gluon Plasma (4)
- Studien (4)
- trials (4)
- ALICE (3)
- COVID-19 (3)
- Heavy Ions (3)
- Jets and Jet Substructure (3)
- chemotherapy (3)
- pp collisions (3)
- Antimicrobial treatment (2)
- Atomic force microscopy (2)
- Beauty production (2)
- Biofilm (2)
- Brownian dynamics simulation (2)
- CDK4/6 (2)
- Cancer genomics (2)
- Charm physics (2)
- Complications (2)
- Deep brain stimulation (2)
- Diagnostik (2)
- Experimental nuclear physics (2)
- Experimental particle physics (2)
- Früherkennung (2)
- Galaktografie (2)
- Galaktomosynthese (2)
- Heavy Quark Production (2)
- Lepton-Nucleon Scattering (experiments) (2)
- Lokalrezidiv (2)
- Low-virulent infection (2)
- MRI (2)
- MRT (2)
- Mamma (2)
- Metastasen (2)
- Molecular dynamics simulation (2)
- Nachsorge (2)
- PD1/PDL1 (2)
- Particle Correlations and Fluctuations (2)
- Particle and resonance production (2)
- Particle correlations and fluctuations (2)
- Pb–Pb collisions (2)
- Prognosefaktoren (2)
- Prädiktivfaktoren (2)
- Prävention (2)
- QCD (2)
- Relativistic heavy-ion collisions (2)
- Richtlinie (2)
- Risiko (2)
- Single electrons (2)
- Single molecule force spectroscopy (2)
- Sonication (2)
- Tomosynthese (2)
- Ultraschall (2)
- biodiversity protection (2)
- breast (2)
- conservation funding (2)
- conservation planning (2)
- decision making (2)
- diagnosis (2)
- follow‑up (2)
- galactography (2)
- galactomosynthesis (2)
- global change (2)
- guideline (2)
- immune reconstitution (2)
- local recurrence (2)
- long non-coding RNA (2)
- macrophage polarization (2)
- malignancy (2)
- post-2020 biodiversity targets (2)
- predictive factors (2)
- prevention (2)
- primary immunodeficiency (2)
- prognostic factors (2)
- risk (2)
- screening (2)
- strategic site selection (2)
- tomosynthesis (2)
- treatment (2)
- treatment/therapy (2)
- ultrasound (2)
- von Willebrand factor (2)
- 900 GeV (1)
- ADAM15 (1)
- ALICE detector (1)
- ARDS (1)
- Active middle ear implants (1)
- Activities of daily living (1)
- Advanced biliary tract cancer (1)
- Advanced breast cancer (1)
- Air traffic (1)
- Allogeneic hematopoietic stem (1)
- Anandamide (1)
- Anti-nuclei (1)
- Antihormone therapy (1)
- Aquaporins (1)
- Artesunate (1)
- Artificial Intelligence (1)
- Ataxia-telangiectasia (1)
- Atherosclerosis (1)
- Auditory system (1)
- BTC (1)
- Bacteria-host interaction (1)
- Bacterial adhesion (1)
- Bidirectional genes (1)
- Biodiversity Data (1)
- Biomonitoring (1)
- Bone conduction devices (1)
- Boosted Jets (1)
- Botanical Collections (1)
- Bromodomänen (1)
- CCL2 (1)
- CD3/19 depletion (1)
- CD34 selection (1)
- COVID (1)
- CRISPR/Cas9 (1)
- CVD biomarker (1)
- CYBA/p22phox (1)
- Cancer (1)
- Cancer genetics (1)
- Cardiomyopathy (1)
- Cardiovascular diseases (1)
- Centrality Class (1)
- Centrality Selection (1)
- Charge fluctuations (1)
- Chemische Sonden (1)
- Chimerism (1)
- Cleanliness level (1)
- Clinical study (1)
- Clinical trial (1)
- Collective Flow, (1)
- Colon capsule endoscopy (1)
- Colorectal cancer (1)
- Comparison with QCD (1)
- Complementation rate (1)
- Complex I (1)
- Consensus statement (1)
- Conservation (1)
- Critical care (1)
- Depression (1)
- Desinfektion von Flugzeugen (1)
- Diatoms (1)
- Digitization (1)
- Disinfection of aircraft (1)
- D’Amico classification (1)
- E/I-Balance (1)
- Electron-pion identification (1)
- Electroweak interaction (1)
- Elliptic flow (1)
- Embryotoxicity (1)
- Emotions (1)
- Endometrial cancer (1)
- Endothelium (1)
- Epigenetics (1)
- Epigenetik (1)
- Europe (1)
- Experimental models of disease (1)
- Extracellular matrix (1)
- Falciparum (1)
- FcpA (1)
- Femtoscopy (1)
- Fibre/foam sandwich radiator (1)
- Fibronectin (1)
- Forschung (1)
- GVHD (1)
- Gamma-Band Activity (1)
- Gene expression (1)
- Genetic testing (1)
- Genomic instability (1)
- Germany (1)
- Gleason score (1)
- Glioblastoma (1)
- HBT (1)
- HDAC4 (1)
- HER2 c-erbB2 (1)
- HER2/neu (1)
- HNO (1)
- HOTAIR (1)
- Hadron production (1)
- Hadron-Hadron Scattering Heavy (1)
- Hadron-hadron interactions (1)
- Hals-Nasen-Ohren-Heilkunde (1)
- Hand-foot syndrome (1)
- Hard Scattering (1)
- Health policy (1)
- Health risk analysis (1)
- Heart transplantation (1)
- Heavy Ion Experiment (1)
- Heavy flavor production (1)
- Heavy flavour production (1)
- Heavy ions (1)
- Heavy-flavour decay muons (1)
- Heavy-flavour production (1)
- Heavy-ion collisions (1)
- Herbaria (1)
- Heregulin (1)
- Hif1α (1)
- Highly infectious diseases (1)
- His-tag (1)
- Hochansteckende Krankheiten (1)
- Human behaviour (1)
- Human prostate (1)
- Inclusive spectra (1)
- Incomplete colonoscopy (1)
- Inflammation (1)
- Influenza (1)
- Intensity interferometry (1)
- Intestinal barrier (1)
- Invariant Mass Distribution (1)
- Ionisation energy loss (1)
- Italy (1)
- JAWSTAT pathway (1)
- Jet Physics (1)
- Jet Substructure (1)
- KCNQ4 (1)
- LHRH receptor (1)
- Lactic acidosis (1)
- Lehre (1)
- Liver cirrhosis (1)
- Low volume prep (1)
- Luftverkehr (1)
- Lymphocytes (1)
- Lymphoid tissues (1)
- MALAT1 (1)
- MGMT (1)
- MM-121 (1)
- Malaria (1)
- Material budget (1)
- Medizinische Chemie (1)
- Membrane protein (1)
- Mental health and psychiatry (1)
- Mesenchymal stem cells (1)
- Metastatic (1)
- Mid-rapidity (1)
- Minimal residual disease (1)
- Minimum Bias (1)
- Mitochondrial disorder (1)
- Mixed hearing loss (1)
- Molecular medicine (1)
- Monte Carlo (1)
- Moviprep (1)
- Multi-Parton Interactions (1)
- Multi-endpoint toxicity study (1)
- Multi-stakeholder approach (1)
- Multi-strange baryons (1)
- Multi-wire proportional drift chamber (1)
- Myocardial infarction (1)
- N-methyl-D-aspartate receptor (1)
- NADPH oxidase (1)
- NCoR1 (1)
- NK cell (1)
- NK cell subset (1)
- NSAIDs (1)
- Nano- and microplastics (1)
- Nanodisc (1)
- Neonatal (1)
- Neural network (1)
- Neuroscience (1)
- Nuclear modification factor (1)
- ORL (1)
- Obesity (1)
- Oncology (1)
- Otorhinolaryngology (1)
- Outcome (1)
- PD-1 (1)
- PD-L1 (1)
- PDGFRβ (1)
- PYTHIA (1)
- Parainfluenza (1)
- Particle and Resonance Production (1)
- Pb–Pb (1)
- Phase 2 (1)
- Phospho-soda (1)
- PillCamColon2 (1)
- Placental barrier (1)
- Plasmodium (1)
- Pneumonia (1)
- Polyps (1)
- Polystyrene (1)
- Portal hypertension (1)
- Pre-emptive immunotherapy (1)
- Primary hemostasis (1)
- Primary prophylaxis (1)
- Production Cross Section (1)
- Produkte zur Desinfektion (1)
- Prognosis (1)
- Prognostic models (1)
- Properties of Hadrons (1)
- Prostate cancer (1)
- Prostate cancer cell lines (1)
- Proton–proton (1)
- Psychiatric disorders (1)
- Psychometrics (1)
- QGP (1)
- Quark Deconfinement (1)
- Quark Gluon Plasma (1)
- Quark Production (1)
- Quark gluon plasma (1)
- Quarkonium (1)
- Questionnaires (1)
- Quinine (1)
- RNA PT (1)
- RNA modification (1)
- Rapidity Range (1)
- Red blood cell transfusion (1)
- Rehabilitation (1)
- Relativistic heavy ion physics (1)
- Research (1)
- Research Article (1)
- Research Infrastructure (1)
- Residency (1)
- Resolution Parameter (1)
- Resonance assignment (1)
- Respiratory syncytial virus (1)
- Rheumatoid arthritis (1)
- Rheumatology (1)
- SARS-CoV-2 (1)
- SARS-CoV‑2 pandemic (1)
- SARS-CoV‑2-Pandemie (1)
- SCT (1)
- SIRT1 (1)
- SNP (1)
- STAT3 (1)
- SUV (1)
- Schizophrenia (1)
- Semantics (1)
- Seribantumab (1)
- Severe malaria (1)
- Single muons (1)
- Single-cell RNA-seq (1)
- Solution-state NMR (1)
- Sorafenib (1)
- Specialist training (1)
- Spontaneous bacterial peritonitis (1)
- Standardized operating procedures (1)
- Standardverfahren (1)
- Stroke (1)
- Strukturbasiertes Design (1)
- Substances for disinfection (1)
- Superinfection (1)
- Surgery (1)
- Sweden (1)
- Systematic Uncertainty (1)
- T-DM1 (1)
- TR (1)
- TRPV4 (1)
- Targeted therapy (1)
- Taxonomy (1)
- Teaching (1)
- Technical data (1)
- Temozolomide (1)
- Thrombosis (1)
- Time Projection Chamber (1)
- Tracking (1)
- Transition radiation detector (1)
- Transverse momentum (1)
- Treatment (1)
- Trigger (1)
- University hospitals (1)
- Universitätskliniken (1)
- Upper respiratory tract infection (1)
- VEGFR-2 (1)
- VEGFR-3 (1)
- Vector Boson Production (1)
- Vitamin (1)
- Weiterbildung (1)
- Xenon-based gas mixture (1)
- accident (1)
- adult (1)
- advanced breast cancer (1)
- agaricomycetes (1)
- allogeneic stem cell transplantation (1)
- anaemia (1)
- anaesthesia in orthopaedics (1)
- anaesthetics (1)
- anti-angiogenic therapy (1)
- antifungals (1)
- antihormone therapy (1)
- ataxia telangiectasia (1)
- biodiversity (1)
- biologicals (1)
- bortezomib (1)
- brain metastases (1)
- bromodomains (1)
- c-kit (1)
- cancer (1)
- cancer surveillance (1)
- cascade model (1)
- cell proliferation (1)
- cell transplantation (1)
- cerebrospinal fluid (1)
- chemical probes (1)
- children (1)
- clinical trial (1)
- cochlea (1)
- combined immunodeficiency (1)
- community ecology (1)
- cross-linking (1)
- dE/dx (1)
- dental implants (1)
- detector (1)
- digestion artifact (1)
- discomfort/pain (1)
- dynamic 18F-FDG PET/CT (1)
- ecological networks (1)
- ecosystem functioning (1)
- ecosystem services (1)
- elderly patients (1)
- epigenetics (1)
- experimental results (1)
- functional connectivity (1)
- geriatric medicine (1)
- glioblastoma (1)
- heavy ion experiments (1)
- human (1)
- human knockout model (1)
- human well-being (1)
- induction regimen (1)
- injury (1)
- inverse stage migration (1)
- iron metabolism (1)
- kidney (1)
- kidney function (1)
- knockout mouse (1)
- lapatinib (1)
- lenalidomide (1)
- leukopenia (1)
- lockdown (1)
- long-term protection (1)
- long36 term protection (1)
- magnetic resonance imaging (1)
- magnetoencephalography (1)
- mass spectrometry (1)
- mechanotransduction (1)
- medicinal chemistry (1)
- medulloblastoma (1)
- metastases (1)
- metastasis (1)
- metastatic (1)
- multiple myeloma (1)
- neural oscillations (1)
- neutralizing antibodies (1)
- neutropenia (1)
- nucleoside analysis (1)
- pancreatic cancer (1)
- pannexin-1 (1)
- pazopanib (1)
- pediatric intensive care (1)
- periodontal probing, (1)
- peri‐implant probing (1)
- pertuzumab (1)
- photosynthesis (1)
- platform switching (1)
- polyacetylenes (1)
- polyines (1)
- polymeric micelle (1)
- polymorphism (1)
- polypept(o)ide (1)
- polyynes (1)
- pre-emptive allogeneic hematopoietic stem cell transplantation (1)
- prognosis (1)
- prostate cancer (1)
- quark gluon plasma (1)
- radical prostatecomy (1)
- radio sensitivity (1)
- radiotherapy (1)
- randomized (1)
- renal failure (1)
- risk factor progression (1)
- risk factors (1)
- schizophrenia (1)
- social-ecological system (1)
- soft tissue sarcoma (STS) (1)
- species identity (1)
- spectra (1)
- spike protein (1)
- stroke (1)
- structure-based design (1)
- subgrouping (1)
- superparamagnetic iron oxide nanoparticles (1)
- surgery (1)
- targeted therapy (1)
- therapy resistance (1)
- thylakoid (1)
- trastuzumab (1)
- trauma (1)
- tumor angiogenesis (1)
- tumor-infiltrating lymphocytes (1)
- two-tissue compartment model (1)
- variants of concern (1)
- xenograft (1)
- √sN N = 2.76 TeV (1)
Institute
- Physik (1072)
- Frankfurt Institute for Advanced Studies (FIAS) (957)
- Informatik (921)
- Medizin (79)
- Biowissenschaften (11)
- Senckenbergische Naturforschende Gesellschaft (6)
- Biochemie und Chemie (4)
- Pharmazie (4)
- Georg-Speyer-Haus (3)
- Informatik und Mathematik (3)
The Transition Radiation Detector (TRD) was designed and built to enhance the capabilities of the ALICE detector at the Large Hadron Collider (LHC). While aimed at providing electron identification and triggering, the TRD also contributes significantly to the track reconstruction and calibration in the central barrel of ALICE. In this paper the design, construction, operation, and performance of this detector are discussed. A pion rejection factor of up to 410 is achieved at a momentum of 1 GeV/c in p-Pb collisions and the resolution at high transverse momentum improves by about 40% when including the TRD information in track reconstruction. The triggering capability is demonstrated both for jet, light nuclei, and electron selection.
The Transition Radiation Detector (TRD) was designed and built to enhance the capabilities of the ALICE detector at the Large Hadron Collider (LHC). While aimed at providing electron identification and triggering, the TRD also contributes significantly to the track reconstruction and calibration in the central barrel of ALICE. In this paper the design, construction, operation, and performance of this detector are discussed. A pion rejection factor of up to 410 is achieved at a momentum of 1 GeV/c in p-Pb collisions and the resolution at high transverse momentum improves by about 40% when including the TRD information in track reconstruction. The triggering capability is demonstrated both for jet, light nuclei, and electron selection.
The Transition Radiation Detector (TRD) was designed and built to enhance the capabilities of the ALICE detector at the Large Hadron Collider (LHC). While aimed at providing electron identification and triggering, the TRD also contributes significantly to the track reconstruction and calibration in the central barrel of ALICE. In this paper the design, construction, operation, and performance of this detector are discussed. A pion rejection factor of up to 410 is achieved at a momentum of 1 GeV/c in p–Pb collisions and the resolution at high transverse momentum improves by about 40% when including the TRD information in track reconstruction. The triggering capability is demonstrated both for jet, light nuclei, and electron selection.
Long-range angular correlations on the near and away side in p–Pb collisions at √sNN=5.02 TeV
(2013)
Angular correlations between charged trigger and associated particles are measured by the ALICE detector in p–Pb collisions at a nucleon–nucleon centre-of-mass energy of 5.02 TeV for transverse momentum ranges within 0.5<pT,assoc<pT,trig<4 GeV/c. The correlations are measured over two units of pseudorapidity and full azimuthal angle in different intervals of event multiplicity, and expressed as associated yield per trigger particle. Two long-range ridge-like structures, one on the near side and one on the away side, are observed when the per-trigger yield obtained in low-multiplicity events is subtracted from the one in high-multiplicity events. The excess on the near-side is qualitatively similar to that recently reported by the CMS Collaboration, while the excess on the away-side is reported for the first time. The two-ridge structure projected onto azimuthal angle is quantified with the second and third Fourier coefficients as well as by near-side and away-side yields and widths. The yields on the near side and on the away side are equal within the uncertainties for all studied event multiplicity and pT bins, and the widths show no significant evolution with event multiplicity or pT. These findings suggest that the near-side ridge is accompanied by an essentially identical away-side ridge.
The first measurement of ϕ-meson production in p-Pb collisions at a nucleon-nucleon centre-of-mass energy sNN−−−√ = 5.02 TeV has been performed with the ALICE apparatus at the LHC. The ϕ-mesons have been identified in the dimuon decay channel in the transverse momentum (pT) range 1<pT<7 GeV/c, both in the p-going (2.03<y<3.53) and the Pb-going (−4.46<y<−2.96) directions, where y stands for the rapidity in the nucleon-nucleon centre-of-mass. Differential cross sections as a function of transverse momentum and rapidity are presented. The forward-backward asymmetry for ϕ-meson production is measured for 2.96<|y|<3.53, resulting in a factor ∼0.5 with no significant pT dependence within the uncertainties. The pT dependence of the ϕ nuclear modification factor RpPb exhibits an enhancement up to a factor 1.6 at pT = 3-4 GeV/c in the Pb-going direction. The pT dependence of the ϕ-meson cross section in pp collisions at s√ = 2.76 TeV, which is used to determine a reference for the p-Pb results, is also presented here for 1<pT<5 GeV/c and 2.5<y<4.
We report on results obtained with the Event Shape Engineering technique applied to Pb-Pb collisions at sNN−−−√=2.76 TeV. By selecting events in the same centrality interval, but with very different average flow, different initial state conditions can be studied. We find the effect of the event-shape selection on the elliptic flow coefficient v2 to be almost independent of transverse momentum pT, as expected if this effect is due to fluctuations in the initial geometry of the system. Charged hadron, pion, kaon, and proton transverse momentum distributions are found to be harder in events with higher-than-average elliptic flow, indicating an interplay between radial and elliptic flow.
Transverse momentum (pT) spectra of pions, kaons, and protons up to pT=20 GeV/c have been measured in Pb-Pb collisions at sNN−−−√=2.76 TeV using the ALICE detector for six different centrality classes covering 0-80%. The proton-to-pion and the kaon-to-pion ratios both show a distinct peak at pT≈3 GeV/c in central Pb-Pb collisions that decreases towards more peripheral collisions. For pT>10 GeV/c, the nuclear modification factor is found to be the same for all three particle species in each centrality interval within systematic uncertainties of 10-20%. This suggests there is no direct interplay between the energy loss in the medium and the particle species composition in the hard core of the quenched jet. For pT<10 GeV/c, the data provide important constraints for models aimed at describing the transition from soft to hard physics.
Transverse momentum (pT) spectra of pions, kaons, and protons up to pT=20 GeV/c have been measured in Pb-Pb collisions at sNN−−−√=2.76 TeV using the ALICE detector for six different centrality classes covering 0-80%. The proton-to-pion and the kaon-to-pion ratios both show a distinct peak at pT≈3 GeV/c in central Pb-Pb collisions that decreases towards more peripheral collisions. For pT>10 GeV/c, the nuclear modification factor is found to be the same for all three particle species in each centrality interval within systematic uncertainties of 10-20%. This suggests there is no direct interplay between the energy loss in the medium and the particle species composition in the hard core of the quenched jet. For pT<10 GeV/c, the data provide important constraints for models aimed at describing the transition from soft to hard physics.
The first study of ϕ-meson production in p-Pb collisions at forward and backward rapidity, at a nucleon-nucleon centre-of-mass energy sNN−−−√=5.02~TeV, has been performed with the ALICE apparatus at the LHC. The ϕ-mesons have been identified in the dimuon decay channel in the transverse momentum (pT) range 1<pT<7 GeV/c, both in the p-going (2.03<y<3.53) and the Pb-going (−4.46<y<−2.96) directions, where y stands for the rapidity in the nucleon-nucleon centre-of-mass, the integrated luminosity amounting to 5.01±0.19~nb−1 and 5.81±0.20~nb−1, respectively, for the two data samples. Differential cross sections as a function of transverse momentum and rapidity are presented. The forward-backward ratio for ϕ-meson production is measured for 2.96<|y|<3.53, resulting in a ratio ∼0.5 with no significant pT dependence within the uncertainties. The pT dependence of the ϕ nuclear modification factor RpPb exhibits an enhancement up to a factor 1.6 at pT = 3-4 GeV/c in the Pb-going direction. The pT dependence of the ϕ-meson cross section in pp collisions at s√ = 2.76 TeV, which is used to determine a reference for the p-Pb results, is also presented here for 1<pT<5 GeV/c and 2.5<y<4 for a 78±3~nb−1 integrated luminosity sample.
The first study of ϕ-meson production in p-Pb collisions at forward and backward rapidity, at a nucleon-nucleon centre-of-mass energy sNN−−−√=5.02~TeV, has been performed with the ALICE apparatus at the LHC. The ϕ-mesons have been identified in the dimuon decay channel in the transverse momentum (pT) range 1<pT<7 GeV/c, both in the p-going (2.03<y<3.53) and the Pb-going (−4.46<y<−2.96) directions, where y stands for the rapidity in the nucleon-nucleon centre-of-mass, the integrated luminosity amounting to 5.01±0.19~nb−1 and 5.81±0.20~nb−1, respectively, for the two data samples. Differential cross sections as a function of transverse momentum and rapidity are presented. The forward-backward ratio for ϕ-meson production is measured for 2.96<|y|<3.53, resulting in a ratio ∼0.5 with no significant pT dependence within the uncertainties. The pT dependence of the ϕ nuclear modification factor RpPb exhibits an enhancement up to a factor 1.6 at pT = 3-4 GeV/c in the Pb-going direction. The pT dependence of the ϕ-meson cross section in pp collisions at s√ = 2.76 TeV, which is used to determine a reference for the p-Pb results, is also presented here for 1<pT<5 GeV/c and 2.5<y<4 for a 78±3~nb−1 integrated luminosity sample.